A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial

A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial

Introduction: Most women develop MS before menopause. Menopausal hot flashes can worsen MS symptoms, and could be relieved with hormone therapy. Our objective was to evaluate feasibility, tolerability and symptom response of Duavee® (bazedoxifene + conjugated estrogen) in a Phase Ib/IIa double-blind...

Full description

Bibliographic Details
Main Authors: Anderson, A. (Author), Bove, R. (Author), Carleton, M. (Author), Chan, J.R (Author), Cooper, J. (Author), Cree, B.A.C (Author), Gelfand, J.M (Author), Graves, J.S (Author), Green, A.J (Author), Henry, R.G (Author), Hills, N.K (Author), Joffe, H. (Author), Krysko, K.M (Author), Rankin, K.A (Author), Rowles, W. (Author), Rush, G. (Author), Zamvil, S.S (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
Estrogen
Gender
Hormone therapy
Menopause
SERM
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items